当前位置:首页 >财报库 > 报告详情

传奇生物Legend Biotech(LEGN)2024年环境、社会和治理(ESG)报告「NASDAQ」(英文版)(46页).pdf

上传人: 1****1 编号:1154173 2025-06-11 46页 18.74MB

下载:

1、Global Headquarters2101 Cottontail LaneSomerset,NJ 08873,USA+1 732 317 2024ENVIRONMENTAL,SOCIAL,AND GOVERNANCE REPORT2024 ESG REPORT2IntroductionCaring for PatientsFostering Operational Efficiency and IntegrityEmpowering Employees and Strengthening CommunitiesSASB IndexTable of ContentsIntroduction3

2、4About this Report5A Message From Our CEO6About Legend Biotech8Approach to ESG10Caring for Patients31Fostering Operational Efficiency and Integrity20Empowering Employees and Strengthening Communities42SASB IndexInnovation at Legend Biotech11Product Safety and Quality15Patient Access and Support16Val

3、uing Employees21Giving Back Within Our Communities30Environmental Management32Occupational Health and Safety37Corporate Governance38Ethics and Integrity40Cybersecurity and Data Privacy41IntroductionThank you for your interest in Legend Biotechs 2024 ESG report.We are pleased to share an overview of

4、our performance and data,highlighting our commitment to integrating ESG principles into our business operations.IN THIS SECTION:ABOUT THIS REPORT A MESSAGE FROM OUR CEO ABOUT LEGEND BIOTECH APPROACH TO ESG 2024 ESG REPORT3IntroductionCaring for PatientsFostering Operational Efficiency and IntegrityE

5、mpowering Employees and Strengthening CommunitiesSASB IndexFor more information or questions,please contact IThe information and data in this report,published on April 10,2025,covers the reporting period from January 1,2024,to December 31,2024.This report was prepared in accordance with the Sustaina

6、bility Accounting Standards Boards(SASB)Biotechnology&Pharmaceuticals Sustainability Accounting Standard,and the Greenhouse Gas(GHG)Protocol Corporate Accounting and Reporting Standard.Weve also reported additional metrics with reference to the Global Reporting Initiative(GRI)Standards.About This Re

word格式文档无特别注明外均可编辑修改,预览文件经过压缩,下载原文更清晰!
三个皮匠报告文库所有资源均是客户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
1. **公司概况**:Legend Biotech是全球细胞疗法领导者,总部位于美国新泽西州,员工超2,600人,研发管线含11项 investigational therapies,已治疗5,000+患者。 2. **ESG治理**:2024年将ESG监督移交Controllership,设立ESG Controller及跨职能委员会,强化治理结构。 3. **创新与研发**:2024年研发投入2.666亿美元,累计超19亿美元;CARVYKTI®获美欧二线治疗批准,提名2024年Prix Galien USA最佳生物技术产品。 4. **患者支持**:CARVYKTI®全球商业化生产扩展至5国,比利时Obelisc工厂投产;MyCARVYKTI®项目支持1,900+患者,3,500+患者及 caregivers 获援助。 5. **员工发展**:推出领导力培训及“Mentor a Legend”项目,47%员工参与股票所有权计划;员工敬业度调查满意度达75%-86%。 6. **社区贡献**:赞助多发性骨髓瘤研究基金会5K跑/走活动,支持医疗教育与研究倡议。
**创新如何驱动?** **患者支持有哪些?** **员工发展计划?**
客服
商务合作
小程序
服务号
折叠